SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007598
Filing Date
2019-08-08
Accepted
2019-08-08 08:51:20
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20190630x10q.htm 10-Q 1690752
2 EX-10.3 idra-20190630ex103517122.htm EX-10.3 55238
3 EX-10.4 idra-20190630ex104ebcc43.htm EX-10.4 27702
4 EX-31.1 idra-20190630ex311302fd0.htm EX-31.1 18380
5 EX-31.2 idra-20190630ex31275d199.htm EX-31.2 18280
6 EX-32.1 idra-20190630ex3210e867e.htm EX-32.1 7942
7 EX-32.2 idra-20190630ex32251ecff.htm EX-32.2 7712
8 GRAPHIC idra20190630ex104ebcc43001.jpg GRAPHIC 29752
9 GRAPHIC idra20190630x10q001.jpg GRAPHIC 14972
10 GRAPHIC idra20190630x10q002.jpg GRAPHIC 7572
11 GRAPHIC idra20190630x10q003.jpg GRAPHIC 8010
12 GRAPHIC idra20190630x10q004.jpg GRAPHIC 7470
13 GRAPHIC idra20190630x10q005.jpg GRAPHIC 9393
  Complete submission text file 0001558370-19-007598.txt   6407850

Data Files

Seq Description Document Type Size
14 EX-101.INS idra-20190630.xml EX-101.INS 1340462
15 EX-101.SCH idra-20190630.xsd EX-101.SCH 44822
16 EX-101.CAL idra-20190630_cal.xml EX-101.CAL 41147
17 EX-101.DEF idra-20190630_def.xml EX-101.DEF 162415
18 EX-101.LAB idra-20190630_lab.xml EX-101.LAB 364390
19 EX-101.PRE idra-20190630_pre.xml EX-101.PRE 300610
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 191007653
SIC: 2836 Biological Products, (No Diagnostic Substances)